High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma

Ribonucleotide reductase subunit M2 may play a role as a potential prognostic biomarker in several cancers. In this study, we evaluated whether RRM2 gene expression is associated with the prognosis of patients with lung adenocarcinoma (LUAD) using publicly available data from The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Cheng-Yu, Du, Liang, Nuerlan, A-Han, Wang, Xiao-Lei, Yang, Yong-Wei, Guo, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906179/
https://www.ncbi.nlm.nih.gov/pubmed/33411689
http://dx.doi.org/10.18632/aging.202292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906179/
https://www.ncbi.nlm.nih.gov/pubmed/33411689
http://dx.doi.org/10.18632/aging.202292

Ejemplares similares